Review of novel aspects of the regulation of ghrelin secretion

Current Drug Metabolism

Volumn 15, Issue 4, 2014, Pages 398-413

  Al Massadi, Omar ^a,b   Lear, Pamela V ^a   Müller, Timo D ^c   López, Miguel ^a   Diéguez, Carlos ^a   Tschöp, Matthias H ^c   Nogueiras, Rubén ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ghrelin; GOAT; Hormones; Nervous system; Nutrients; Obesity

Indexed keywords

ADIPOCYTOKINE; CHOLECYSTOKININ; CYTOKINE; ESTROGEN; ESTRONE DERIVATIVE; EXENDIN 4; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCOCORTICOID; GROWTH HORMONE; INSULIN; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; OLEOYL ESTRONE; OXYNTOMODULIN; PEPTIDASE; PEPTIDE YY; PREPROGLUCAGON; SOMATOMEDIN C; SOMATOSTATIN; TESTOSTERONE; UNCLASSIFIED DRUG; GHRELIN RECEPTOR;

ANOREXIA NERVOSA; ANTHROPOMETRIC PARAMETERS; APPETITE DISORDER; AUTONOMIC NERVOUS SYSTEM; BODY WEIGHT; CACHEXIA; EATING DISORDER; ENERGY BALANCE; EXERCISE; FOOD INTAKE; GASTROINTESTINAL TRACT; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; INTESTINE FUNCTION; INTESTINE INNERVATION; METABOLIC RATE; NERVE STIMULATION; NONHUMAN; NUTRITIONAL STATUS; OBESITY; PARASYMPATHETIC NERVE CELL; PROTEIN STRUCTURE; REVIEW; SENSORY NERVE; SIGNAL TRANSDUCTION; STOMACH FUNCTION; SYMPATHETIC NERVE CELL; TASTE BUD; TEMPERATURE; ANIMAL; BIOLOGICAL MODEL; EATING; GENETICS; METABOLISM; SECRETION (PROCESS);

ANIMALS; EATING; GASTROINTESTINAL TRACT; GHRELIN; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, GHRELIN;

EID: 84915757851     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200215666140505153723     Document Type: Review

References (236)

1. Kojima, M.; Hosoda, H.; Date, Y.; Nakazato, M.; Matsuo, H.; Kangawa, K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999, 402 (6762), 656-60
2. Nishi, Y.; Yoh, J.; Hiejima, H.; Kojima, M. Structures and molecular forms of the ghrelin-family peptides. Peptides, 2011, 32 (11), 2175-82
3. Gutierrez, J. A.; Solenberg, P. J.; Perkins, D. R.; Willency, J. A.; Knierman, M. D.; Jin, Z.; Witcher, D. R.; Luo, S.; Onyia, J. E.; Hale, J. E. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. U. S. A., 2008, 105 (17), 6320-5
4. Halem, H. A.; Taylor, J. E.; Dong, J. Z.; Shen, Y.; Datta, R.; Abizaid, A.; Diano, S.; Horvath, T. L.; Culler, M. D. A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain. Neuroendocrinology, 2005, 81 (5), 339-49
5. Toshinai, K.; Yamaguchi, H.; Sun, Y.; Smith, R. G.; Yamanaka, A.; Sakurai, T.; Date, Y.; Mondal, M. S.; Shimbara, T.; Kawagoe, T.; Murakami, N.; Miyazato, M.; Kangawa, K.; Nakazato, M. Desacyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology, 2006, 147 (5), 2306-14
6. Lear, P. V.; Iglesias, M. J.; Feijoo-Bandin, S.; Rodriguez-Penas, D.; Mosquera-Leal, A.; Garcia-Rua, V.; Gualillo, O.; Ghe, C.; Arnoletti, E.; Muccioli, G.; Dieguez, C.; Gonzalez-Juanatey, J. R.; Lago, F. Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes. Endocrinology, 2010, 151 (7), 3286-98
7. Heppner, K. M.; Piechowski, C. L.; Muller, A.; Ottaway, N.; Sisley, S.; Smiley, D. L.; Habegger, K. M.; Pfluger, P. T.; Dimarchi, R.; Biebermann, H.; Tschop, M.H.; Sandoval, D. A.; Perez-Tilve, D. Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors. Diabetes, 2014, 63 (1), 122-31
8. Tschop, M.; Smiley, D. L.; Heiman, M.L. Ghrelin induces adiposity in rodents. Nature, 2000, 407 (6806), 908-13
9. Perez-Tilve, D.; Heppner, K.; Kirchner, H.; Lockie, S. H.; Woods, S.C.; Smiley, D. L.; Tschop, M.; Pfluger, P. Ghrelin-induced adiposity is independent of orexigenic effects. F.A.S.E.B. J., 2011, 25 (8), 2814-22
10. Kamegai, J.; Tamura, H.; Shimizu, T.; Ishii, S.; Sugihara, H.; Wakabayashi, I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes, 2001, 50 (11), 2438-43
11. Nakazato, M.; Murakami, N.; Date, Y.; Kojima, M.; Matsuo, H.; Kangawa, K.; Matsukura, S. A role for ghrelin in the central regulation of feeding. Nature, 2001, 409 (6817), 194-8
12. Cowley, M. A.; Smith, R. G.; Diano, S.; Tschop, M.; Pronchuk, N.; Grove, K. L.; Strasburger, C. J.; Bidlingmaier, M.; Esterman, M.; Heiman, M.L.; Garcia-Segura, L. M.; Nillni, E. A.; Mendez, P.; Low, M. J.; Sotonyi, P.; Friedman, J.M.; Liu, H.; Pinto, S.; Colmers, W. F.; Cone, R. D.; Horvath, T. L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron, 2003, 37 (4), 649-61
13. Seoane, L. M.; Lopez, M.; Tovar, S.; Casanueva, F. F.; Senaris, R.; Dieguez, C. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology, 2003, 144 (2), 544-51
14. Lage, R.; Vazquez, M. J.; Varela, L.; Saha, A. K.; Vidal-Puig, A.; Nogueiras, R.; Dieguez, C.; Lopez, M. Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. F.A.S.E.B. J., 2010, 24 (8), 2670-9
15. Lopez, M.; Lage, R.; Saha, A. K.; Perez-Tilve, D.; Vazquez, M. J.; Varela, L.; Sangiao-Alvarellos, S.; Tovar, S.; Raghay, K.; Rodriguez-Cuenca, S.; Deoliveira, R. M.; Castaneda, T.; Datta, R.; Dong, J. Z.; Culler, M.; Sleeman, M. W.; Alvarez, C. V.; Gallego, R.; Lelliott, C. J.; Carling, D.; Tschop, M.H.; Dieguez, C.; Vidal-Puig, A. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab., 2008, 7 (5), 389-99
16. Andrews, Z. B.; Liu, Z.-W.; Walllingford, N.; Erion, D. M.; Borok, E.; Friedman, J.M.; Tschop, M.H.; Shanabrough, M.; Cline, G.; Shulman, G. I.; Coppola, A.; Gao, X.-B.; Horvath, T. L.; Diano, S. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature, 2008, 454 (7206), 846-51
17. Ramirez, S.; Martins, L.; Jacas, J.; Carrasco, P.; Pozo, M.; Clotet, J.; Serra, D.; Hegardt, F. G.; Dieguez, C.; Lopez, M.; Casals, N. Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin. Diabetes, 2013, 62 (7), 2329-37
18. Andrews, Z. B.; Erion, D. M.; Beiler, R.; Choi, C. S.; Shulman, G. I.; Horvath, T. L. Uncoupling protein-2 decreases the lipogenic actions of ghrelin. Endocrinology, 2010, 151 (5), 2078-86
19. Velasquez, D. A.; Martinez, G.; Romero, A.; Vazquez, M. J.; Boit, K. D.; Dopeso-Reyes, I. G.; Lopez, M.; Vidal, A.; Nogueiras, R.; Dieguez, C. The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin. Diabetes, 2011, 60 (4), 1177-85
20. Kola, B.; Farkas, I.; Christ-Crain, M.; Wittmann, G.; Lolli, F.; Amin, F.; Harvey-White, J.; Liposits, Z.; Kunos, G.; Grossman, A. B.; Fekete, C.; Korbonits, M. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLOS ONE, 2008, 3 (3), e1797
21. Senin, L. L.; Al-Massadi, O.; Folgueira, C.; Castelao, C.; Pardo, M.; Barja-Fernandez, S.; Roca-Rivada, A.; Amil, M.; Crujeiras, A. B.; Garcia-Caballero, T.; Gabellieri, E.; Leis, R.; Dieguez, C.; Pagotto, U.; Casanueva, F. F.; Seoane, L. M. The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake. PLOS ONE, 2013, 8 (11), e80339
22. Romero-Pico, A.; Vazquez, M. J.; Gonzalez-Touceda, D.; Folgueira, C.; Skibicka, K. P.; Alvarez-Crespo, M.; Van Gestel, M. A.; Velasquez, D. A.; Schwarzer, C.; Herzog, H.; Lopez, M.; Adan, R. A.; Dickson, S. L.; Dieguez, C.; Nogueiras, R. Hypothalamic kappa-opioid receptor modulates the orexigenic effect of ghrelin. Neuropsychopharmacology, 2013, 38 (7), 1296-307
23. Ariyasu, H.; Takaya, K.; Tagami, T.; Ogawa, Y.; Hosoda, K.; Akamizu, T.; Suda, M.; Koh, T.; Natsui, K.; Toyooka, S.; Shirakami, G.; Usui, T.; Shimatsu, A.; Doi, K.; Hosoda, H.; Kojima, M.; Kangawa, K.; Nakao, K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelinlike immunoreactivity levels in humans. J. Clin. Endocrinol. Metab., 2001, 86 (10), 4753-8
24. Dornonville de la Cour, C.; Bjorkqvist, M.; Sandvik, A. K.; Bakke, I.; Zhao, C. M.; Chen, D.; Hakanson, R. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul. Pept., 2001, 99 (2-3), 141-50
25. Date, Y.; Kojima, M.; Hosoda, H.; Sawaguchi, A.; Mondal, M. S.; Suganuma, T.; Matsukura, S.; Kangawa, K.; Nakazato, M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology, 2000, 141 (11), 4255-61
26. Sakata, I.; Nakamura, K.; Yamazaki, M.; Matsubara, M.; Hayashi, Y.; Kangawa, K.; Sakai, T. Ghrelin-producing cells exist as two types of cells, closed-and opened-type cells, in the rat gastrointestinal tract. Peptides, 2002, 23 (3), 531-6
27. Mizutani, M.; Atsuchi, K.; Asakawa, A.; Matsuda, N.; Fujimura, M.; Inui, A.; Kato, I.; Fujimiya, M. Localization of acyl ghrelinand des-acyl ghrelin-immunoreactive cells in the rat stomach and their responses to intragastric pH. Am. J. Physiol. Gastrointest. Liver Physiol., 2009, 297 (5), G974-80
28. Solcia, E.; Rindi, G.; Buffa, R.; Fiocca, R.; Capella, C. Gastric endocrine cells: types, function and growth. Regul. Pept., 2000, 93 (1-3), 31-5
29. Hosoda, H.; Kojima, M.; Matsuo, H.; Kangawa, K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun., 2000, 279 (3), 909-13
30. DelParigi, A.; Tschop, M.; Heiman, M.L.; Salbe, A.D.; Vozarova, B.; Sell, S.M.; Bunt, J.C.; Tataranni, P.A. High circulating ghrelin: a potential cause for hyperphagia and obesity in praderwilli syndrome. J. Clin. Endocrinol. Metab., 2002, 87 (12), 5461-4
31. Cummings, D. E.; Clement, K.; Purnell, J. Q.; Vaisse, C.; Foster, K. E.; Frayo, R. S.; Schwartz, M. W.; Basdevant, A.; Weigle, D.S. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat. Med., 2002, 8 (7), 643-4
32. Cummings, D. E.; Purnell, J. Q.; Frayo, R. S.; Schmidova, K.; Wisse, B. E.; Weigle, D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes, 2001, 50 (8), 1714-9
33. Kirchner, H.; Gutierrez, J. A.; Solenberg, P. J.; Pfluger, P. T.; Czyzyk, T. A.; Willency, J. A.; Schurmann, A.; Joost, H.-G.; Jandacek, R. J.; Hale, J. E.; Heiman, M.L.; Tschop, M.H. GOAT links dietary lipids with the endocrine control of energy balance. Nat. Med., 2009, 15 (7), 741-5
34. Prudom, C.; Liu, J.; Patrie, J.; Gaylinn, B. D.; Foster-Schubert, K. E.; Cummings, D. E.; Thorner, M. O.; Geysen, H.M. Comparison of competitive radioimmunoassays and two-site sandwich assays for the measurement and interpretation of plasma ghrelin levels. J. Clin. Endocrinol. Metab., 2010, 95 (5), 2351-8
35. Drazen, D. L.; Vahl, T. P.; D'Alessio, D. A.; Seeley, R. J.; Woods, S.C. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology, 2006, 147 (1), 23-30
36. Williams, D. L.; Cummings, D. E.; Grill, H. J.; Kaplan, J.M. Mealrelated ghrelin suppression requires postgastric feedback. Endocrinology, 2003, 144 (7), 2765-7
37. Overduin, J.; Frayo, R. S.; Grill, H. J.; Kaplan, J.M.; Cummings, D. E. Role of the duodenum and macronutrient type in ghrelin regulation. Endocrinology, 2005, 146 (2), 845-50
38. Al Massadi, O.; Pardo, M.; Roca-Rivada, A.; Castelao, C.; Casanueva, F. F.; Seoane, L. M. Macronutrients act directly on the stomach to regulate gastric ghrelin release. J. Endocrinol. Invest., 2010, 33 (9), 599-602
39. Tschop, M.; Flora, D. B.; Mayer, J. P.; Heiman, M.L. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats. Obes. Res., 2002, 10 (10), 991-9
40. Foster-Schubert, K. E.; Overduin, J.; Prudom, C. E.; Liu, J.; Callahan, H. S.; Gaylinn, B. D.; Thorner, M. O.; Cummings, D. E. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J. Clin. Endocrinol. Metab., 2008, 93 (5), 1971-9
41. Hass, N.; Schwarzenbacher, K.; Breer, H. T1R3 is expressed in brush cells and ghrelin-producing cells of murine stomach. Cell Tissue Res., 2010, 339 (3), 493-504
42. Shin, Y.-K.; Martin, B.; Kim, W.; White, C. M.; Ji, S.; Sun, Y.; Smith, R. G.; Sevigny, J.; Tschop, M.H.; Maudsley, S.; Egan, J.M. Ghrelin is produced in taste cells and ghrelin receptor null mice show reduced taste responsivity to salty (NaCl) and sour (citric acid) tastants. PLOS ONE, 2010, 5 (9), e12729
43. Janssen, S.; Laermans, J.; Verhulst, P.-J.; Thijs, T.; Tack, J.; Depoortere, I. Bitter taste receptors and α-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proc. Natl. Acad. Sci. U. S. A., 2011, 108 (5), 2094-9
44. Powley, T. L. The ventromedial hypothalamic syndrome, satiety, and a cephalic phase hypothesis. Psychol. Rev., 1977, 84 (1), 89-126
45. Woods, S.C.; Vasselli, J. R.; Kaestner, E.; Szakmary, G. A.; Milburn, P.; Vitiello, M. V. Conditioned insulin secretion and meal feeding in rats. J. Comp. Physiol. Psychol., 1977, 91 (1), 128-33
46. Vahl, T. P.; Drazen, D. L.; Seeley, R. J.; D'Alessio, D. A.; Woods, S.C. Meal-anticipatory glucagon-like peptide-1 secretion in rats. Endocrinology, 2010, 151 (2), 569-75
47. Sugino, T.; Hasegawa, Y.; Kikkawa, Y.; Yamaura, J.; Yamagishi, M.; Kurose, Y.; Kojima, M.; Kangawa, K.; Terashima, Y. A transient ghrelin surge occurs just before feeding in a scheduled meal-fed sheep. Biochem. Biophys. Res. Commun., 2002, 295 (2), 255-60
48. Blum, I. D.; Patterson, Z.; Khazall, R.; Lamont, E. W.; Sleeman, M. W.; Horvath, T. L.; Abizaid, A. Reduced anticipatory locomotor responses to scheduled meals in ghrelin receptor deficient mice. Neuroscience, 2009, 164 (2), 351-9
49. Verbaeys, I.; Tolle, V.; Swennen, Q.; Zizzari, P.; Buyse, J.; Epelbaum, J.; Cokelaere, M. Scheduled feeding results in adipogenesis and increased acylated ghrelin. Am. J. Physiol. Endocrinol. Metab., 2011, 300 (6), E1103-11
50. Zizzari, P.; Hassouna, R.; Longchamps, R.; Epelbaum, J.; Tolle, V. Meal anticipatory rise in acylated ghrelin at dark onset is blunted after long-term fasting in rats. J. Neuroendocrinol., 2011, 23 (9), 804-14
51. Arosio, M.; Ronchi, C. L.; Beck-Peccoz, P.; Gebbia, C.; Giavoli, C.; Cappiello, V.; Conte, D.; Peracchi, M. Effects of modified sham feeding on ghrelin levels in healthy human subjects. Am. J. Physiol. Endocrinol. Metab., 2004, 89 (10), 5101-4
52. Sugino, T.; Hasegawa, Y.; Kurose, Y.; Kojima, M.; Kangawa, K.; Terashima, Y. Effects of ghrelin on food intake and neuroendocrine function in sheep. Anim. Reprod. Sci., 2004, 82-83, 183-94
53. Seoane, L. M.; Al-Massadi, O.; Caminos, J. E.; Tovar, S. A.; Dieguez, C.; Casanueva, F. F. Sensory stimuli directly acting at the central nervous system regulate gastric ghrelin secretion. an ex vivo organ culture study. Endocrinology, 2007, 148 (8), 3998-4006
54. Konturek, S. J.; Konturek, J. W.; Pawlik, T.; Brzozowski, T. Braingut axis and its role in the control of food intake. J. Physiol. Pharmacol., 2004, 55 (1 Pt 2), 137-54
55. Sawchenko, P. E. Central connections of the sensory and motor nuclei of the vagus nerve. J. Auton. Nerv. Syst., 1983, 9 (1), 13-26
56. Konturek, P. C.; Konturek, S. J.; Burnat, G.; Brzozowski, T.; Brzozowska, I.; Reiter, R. J. Dynamic physiological and molecular changes in gastric ulcer healing achieved by melatonin and its precursor L-tryptophan in rats. J. Pineal Res., 2008, 45 (2), 180-90
57. Burdyga, G.; Lal, S.; Varro, A.; Dimaline, R.; Thompson, D. G.; Dockray, G. J. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J. Neurosci., 2004, 24 (11), 2708-15
58. Itoh, T.; Nagaya, N.; Yoshikawa, M.; Fukuoka, A.; Takenaka, H.; Shimizu, Y.; Haruta, Y.; Oya, H.; Yamagishi, M.; Hosoda, H.; Kangawa, K.; Kimura, H. Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2004, 170 (8), 879-82
59. Schulpis, K. H.; Papassotiriou, I.; Vounatsou, M.; Karikas, G. A.; Tsakiris, S.; Chrousos, G. P. Morning preprandial plasma ghrelin and catecholamine concentrations in patients with phenylketonuria and normal controls: evidence for catecholamine-mediated ghrelin regulation. J. Clin. Endocrinol. Metab., 2004, 89 (8), 3983-7
60. Mundinger, T. O.; Cummings, D. E.; Taborsky, G. J., Jr. Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology, 2006, 147 (6), 2893-901
61. de la Cour, C. D.; Norlen, P.; Hakanson, R. Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study. Regul. Pept., 2007, 143 (1-3), 118-26
62. Hosoda, H.; Kangawa, K. The autonomic nervous system regulates gastric ghrelin secretion in rats. Regul. Pept., 2008, 146 (1-3), 12-8
63. Zhao, T. J.; Sakata, I.; Li, R. L.; Liang, G.; Richardson, J. A.; Brown, M. S.; Goldstein, J. L.; Zigman, J.M. Ghrelin secretion stimulated by {beta}1-adrenergic receptors in cultured ghrelinoma cells and in fasted mice. Proc. Natl. Acad. Sci. U. S. A., 2010, 107 (36), 15868-73
64. Nakahara, K.; Okame, R.; Katayama, T.; Miyazato, M.; Kangawa, K.; Murakami, N. Nutritional and environmental factors affecting plasma ghrelin and leptin levels in rats. J. Endocrinol., 2010, 207 (1), 95-103
65. Williams, D. L.; Grill, H. J.; Cummings, D. E.; Kaplan, J.M. Vagotomy dissociates short-and long-term controls of circulating ghrelin. Endocrinology, 2003, 144 (12), 5184-7
66. Maier, C.; Schaller, G.; Buranyi, B.; Nowotny, P.; Geyer, G.; Wolzt, M.; Luger, A. The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. J. Clin. Endocrinol. Metab., 2004, 89 (9), 4729-33
67. Erlanson-Albertsson, C.; Lindqvist, A. Vagotomy and accompanying pyloroplasty down-regulates ghrelin mRNA but does not affect ghrelin secretion. Regul. Pept., 2008, 151 (1-3), 14-8
68. Murakami, N.; Hayashida, T.; Kuroiwa, T.; Nakahara, K.; Ida, T.; Mondal, M. S.; Nakazato, M.; Kojima, M.; Kangawa, K. Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. J. Endocrinol., 2002, 174 (2), 283-8
69. Lee, H.-M.; Wang, G.; Englander, E. W.; Kojima, M.; Greeley, G. H., Ghrelin J.R., a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology, 2002, 143 (1), 185-90
70. Maier, C.; Riedl, M.; Vila, G.; Nowotny, P.; Wolzt, M.; Clodi, M.; Ludvik, B.; Luger, A. Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity. Diabetes, 2008, 57 (9), 2332-40
71. Cummings, D. E.; Weigle, D.S.; Frayo, R. S.; Breen, P.A.; Ma, M. K.; Dellinger, E. P.; Purnell, J. Q. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med., 2002, 346 (21), 1623-30
72. Purnell, J. Q.; Weigle, D.S.; Breen, P.; Cummings, D. E. Ghrelin levels correlate with insulin levels, insulin resistance, and highdensity lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J. Clin. Endocrinol. Metab., 2003, 88 (12), 5747-52
73. Tschop, M.; Weyer, C.; Tataranni, P.A.; Devanarayan, V.; Ravussin, E.; Heiman, M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes, 2001, 50 (4), 707-9
74. Briatore, L.; Andraghetti, G.; Cordera, R. Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. Eur. J. Endocrinol., 2003, 149 (5), 403-6
75. Saad, M. F.; Bernaba, B.; Hwu, C.-M.; Jinagouda, S.; Fahmi, S.; Kogosov, E.; Boyadjian, R. Insulin regulates plasma ghrelin concentration. J. Clin. Endocrinol. Metab., 2002, 87 (8), 3997-4000
76. Flanagan, D. E.; Evans, M.L.; Monsod, T. P.; Rife, F.; Heptulla, R. A.; Tamborlane, W. V.; Sherwin, R. S. The influence of insulin on circulating ghrelin. Am. J. Physiol. Endocrinol. Metab., 2003, 284 (2), E313-6
77. Drucker, D. J. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care, 2003, 26 (10), 2929-40
78. Arvat, E.; Maccagno, B.; Ramunni, J.; Giordano, R.; DiVito, L.; Broglio, F.; Maccario, M.; Camanni, F.; Ghigo, E. Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjects. Pituitary, 2000, 3 (3), 169-73
79. Gomez, J.M.; Espadero, R. M.; Escobar-Jimenez, F.; Hawkins, F.; Pico, A.; Herrera-Pombo, J. L.; Vilardell, E.; Duran, A.; Mesa, J.; Faure, E.; Sanmarti, A. Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin. Endocrinol., 2002, 56 (3), 329-34
80. Kishimoto, M.; Okimura, Y.; Nakata, H.; Kudo, T.; Iguchi, G.; Takahashi, Y.; Kaji, H.; Chihara, K. Cloning and characterization of the 5(')-flanking region of the human ghrelin gene. Biochem. Biophys. Res. Commun., 2003, 305 (1), 186-92
81. Kamegai, J.; Tamura, H.; Shimizu, T.; Ishii, S.; Sugihara, H.; Oikawa, S. Effects of insulin, leptin, and glucagon on ghrelin secretion from isolated perfused rat stomach. Regul. Pept., 2004, 119 (1-2), 77-81
82. Hirsh, D.; Heinrichs, C.; Leenders, B.; Wong, A. C. K.; Cummings, D. E.; Chanoine, J.-P. Ghrelin is suppressed by glucagon and does not mediate glucagon-related growth hormone release. Horm. Res., 2005, 63 (3), 111-8
83. Arafat, A. M.; Perschel, F. H.; Otto, B.; Weickert, M. O.; Rochlitz, H.; Schofl, C.; Spranger, J.; Mohlig, M.; Pfeiffer, A. F. H. Glucagon suppression of ghrelin secretion is exerted at hypothalamus-pituitary level. J. Clin. Endocrinol. Metab., 2006, 91 (9), 3528-33
84. Arafat, M. A.; Otto, B.; Rochlitz, H.; Tschop, M.; Bahr, V.; Mohlig, M.; Diederich, S.; Spranger, J.; Pfeiffer, A. F. H. Glucagon inhibits ghrelin secretion in humans. Eur. J. Endocrinol., 2005, 153 (3), 397-402
85. Shimatsu, A.; Kato, Y.; Matsushita, N.; Ohta, H.; Kabayama, Y.; Imura, H. Glucagon-induced somatostatin release from perifused rat hypothalamus: calcium dependency and effect of cysteamine treatment. Neurosci. Lett., 1983, 37 (3), 285-9
86. Rubino, F.; Gagner, M.; Gentileschi, P.; Kini, S.; Fukuyama, S.; Feng, J.; Diamond, E. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann. Surg., 2004, 240 (2), 236-42
87. Turton, M. D.; O'Shea, D.; Gunn, I.; Beak, S. A.; Edwards, C. M.; Meeran, K.; Choi, S. J.; Taylor, G. M.; Heath, M. M.; Lambert, P. D.; Wilding, J. P.; Smith, D. M.; Ghatei, M. A.; Herbert, J.; Bloom, S. R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature, 1996, 379 (6560), 69-72
88. Wettergren, A.; Petersen, H.; Orskov, C.; Christiansen, J.; Sheikh, S. P.; Holst, J. J. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand. J. Gastroenterol., 1994, 29 (6), 501-5
89. Imeryuz, N.; Yegen, B. C.; Bozkurt, A.; Coskun, T.; Villanueva-Penacarrillo, M.L.; Ulusoy, N. B. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am. J. Physiol., 1997, 273 (4 Pt 1), G920-7
90. Castaneda, T. R.; Tong, J.; Datta, R.; Culler, M.; Tschop, M.H. Ghrelin in the regulation of body weight and metabolism. Front. Neuroendocrinol., 2010, 31 (1), 44-60
91. Djurhuus, C. B.; Hansen, T. K.; Gravholt, C.; Orskov, L.; Hosoda, H.; Kangawa, K.; Jorgensen, J. O. L.; Holst, J. J.; Schmitz, O. Circulating levels of ghrelin and GLP-1 are inversely related during glucose ingestion. Horm. Metab. Res., 2002, 34 (7), 411-3
92. Lippl, F.; Kircher, F.; Erdmann, J.; Allescher, H.-D.; Schusdziarra, V. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. Regul. Pept., 2004, 119 (1-2), 93-8
93. Eissele, R.; Koop, H.; Arnold, R. Effect of glucagon-like peptide-1 on gastric somatostatin and gastrin secretion in the rat. Scand. J. Gastroenterol., 1990, 25 (5), 449-54
94. Patterson, M.; Murphy, K. G.; Patel, S. R.; Patel, N. A.; Greenwood, H. C.; Cooke, J. H.; Campbell, D.; Bewick, G. A.; Ghatei, M. A.; Bloom, S. R. Hypothalamic injection of oxyntomodulin suppresses circulating ghrelin-like immunoreactivity. Endocrinology, 2009, 150 (8), 3513-20
95. Hagemann, D.; Holst, J. J.; Gethmann, A.; Banasch, M.; Schmidt, W. E.; Meier, J. J. Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion. Regul. Pept., 2007, 143 (1-3), 64-8
96. Meneilly, G. S.; Greig, N.; Tildesley, H.; Habener, J. F.; Egan, J.M.; Elahi, D. Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes. Diabetes Care, 2003, 26 (10), 2835-41
97. Perez-Tilve, D.; Gonzalez-Matias, L.; Alvarez-Crespo, M.; Leiras, R.; Tovar, S.; Dieguez, C.; Mallo, F. Exendin-4 potently decreases ghrelin levels in fasting rats. Diabetes, 2007, 56 (1), 143-51
98. Egan, J.M.; Clocquet, A. R.; Elahi, D. The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J. Clin. Endocrinol. Metab., 2002, 87 (3), 1282-90
99. Doggrell, S. A. Recent evidence of sustained benefit with exenatide in Type 2 diabetes. Expert Opin. Pharmacother., 2006, 7 (14), 2003-6
100. Rudovich, N. N.; Dick, D.; Moehlig, M.; Otto, B.; Spranger, J.; Rochlitz, H. J.; Ristow, M.; Tschoep, M.; Pfeiffer, A. F. H. Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine. Regul. Pept., 2005, 127 (1-3), 95-9
101. Banasch, M.; Bulut, K.; Hagemann, D.; Schrader, H.; Holst, J. J.; Schmidt, W. E.; Meier, J. J. Glucagon-like peptide 2 inhibits ghrelin secretion in humans. Regul. Pept., 2006, 137 (3), 173-8
102. Bell, G. I.; Sanchez-Pescador, R.; Laybourn, P. J.; Najarian, R. C. Exon duplication and divergence in the human preproglucagon gene. Nature, 1983, 304 (5924), 368-71
103. Orskov, C.; Holst, J. J. Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). Scand. J. Clin. Lab. Invest., 1987, 47 (2), 165-74
104. Yusta, B.; Huang, L.; Munroe, D.; Wolff, G.; Fantaske, R.; Sharma, S.; Demchyshyn, L.; Asa, S. L.; Drucker, D. J. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology, 2000, 119 (3), 744-55
105. Cohen, M. A.; Ellis, S.M.; Le Roux, C. W.; Batterham, R. L.; Park, A.; Patterson, M.; Frost, G. S.; Ghatei, M. A.; Bloom, S. R. Oxyntomodulin suppresses appetite and reduces food intake in humans. J. Clin. Endocrinol. Metab., 2003, 88 (10), 4696-701
106. Brennan, I. M.; Feltrin, K. L.; Horowitz, M.; Smout, A. J. P. M.; Meyer, J. H.; Wishart, J.; Feinle-Bisset, C. Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2005, 288 (6), R1477-85
107. Kobelt, P.; Tebbe, J. J.; Tjandra, I.; Stengel, A.; Bae, H.-G.; Andresen, V.; van der Voort, I. R.; Veh, R. W.; Werner, C. R.; Klapp, B. F.; Wiedenmann, B.; Wang, L.; Tache, Y.; Monnikes, H. CCK inhibits the orexigenic effect of peripheral ghrelin. Regul. Integr. Comp. Physiol., 2005, 288 (3), R751-8
108. Brennan, I. M.; Otto, B.; Feltrin, K. L.; Meyer, J. H.; Horowitz, M.; Feinle-Bisset, C. Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men. Peptides, 2007, 28 (3), 607-11
109. Batterham, R. L.; Cohen, M. A.; Ellis, S.M.; Le Roux, C. W.; Withers, D. J.; Frost, G. S.; Ghatei, M. A.; Bloom, S. R. Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med., 2003, 349 (10), 941-8
110. Batterham, R. L.; Cowley, M. A.; Small, C. J.; Herzog, H.; Cohen, M. A.; Dakin, C. L.; Wren, A. M.; Brynes, A. E.; Low, M. J.; Ghatei, M. A.; Cone, R. D.; Bloom, S. R. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature, 2002, 418 (6898), 650-4
111. Tschop, M.; Castaneda, T. R.; Joost, H. G.; Thone-Reineke, C.; Ortmann, S.; Klaus, S.; Hagan, M. M.; Chandler, P. C.; Oswald, K. D.; Benoit, S.C.; Seeley, R. J.; Kinzig, K. P.; Moran, T. H.; Becksickinger, A. G.; Koglin, N.; Rodgers, R. J.; Blundell, J. E.; Ishii, Y.; Beattie, A. H.; Holch, P.; Allison, D. B.; Raun, K.; Madsen, K.; Wulff, B. S.; Stidsen, C. E.; Birringer, M.; Kreuzer, O. J.; Schindler, M.; Arndt, K.; Rudolf, K.; Mark, M.; Deng, X. Y.; Whitcomb, D. C.; Halem, H.; Taylor, J.; Dong, J.; Datta, R.; Culler, M.; Craney, S.; Flora, D.; Smiley, D.; Heiman, M.L. Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature, 2004, 430 (6996)
112. Riediger, T.; Bothe, C.; Becskei, C.; Lutz, T. A. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression. Neuroendocrinology, 2004, 79 (6), 317-26
113. Green, P. K.; Wilkinson, C. W.; Woods, S.C. Intraventricular corticosterone increases the rate of body weight gain in underweight adrenalectomized rats. Endocrinology, 1992, 130 (1), 269-75
114. Dallman, M. F. Fast glucocorticoid feedback favors 'the munchies'. Trends Endocrinol. Metab., 2003, 14 (9), 394-6
115. Werbel, S. S.; Ober, K. P.A.cute adrenal insufficiency. Endocrinol. Metab. Clin. North Am., 1993, 22 (2), 303-28
116. Mayo-Smith, W.; Hayes, C. W.; Biller, B. M.; Klibanski, A.; Rosenthal, H.; Rosenthal, D. I. Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology, 1989, 170 (2), 515-8
117. Otto, B.; Tschop, M.; Heldwein, W.; Pfeiffer, A. F. H.; Diederich, S. Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur. J. Endocrinol., 2004, 151 (1), 113-7
118. Proulx, K.; Vahl, T. P.; Drazen, D. L.; Woods, S.C.; Seeley, R. J. The effect of adrenalectomy on ghrelin secretion and orexigenic action. J. Neuroendocrinol., 2005, 17 (7), 445-51
119. Giordano, R.; Picu, A.; Pagotto, U.; De Iasio, R.; Bonelli, L.; Prodam, F.; Broglio, F.; Marafetti, L.; Pasquali, R.; Maccario, M.; Ghigo, E.; Arvat, E. The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease. Eur. J. Endocrinol., 2005, 153 (4), 535-43
120. Tolle, V.; Bassant, M.-H.; Zizzari, P.; Poindessous-Jazat, F.; Tomasetto, C.; Epelbaum, J.; Bluet-Pajot, M.-T. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology, 2002, 143 (4), 1353-61
121. Weigle, D.S.; Cummings, D. E.; Newby, P. D.; Breen, P.A.; Frayo, R. S.; Matthys, C. C.; Callahan, H. S.; Purnell, J. Q. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J. Clin. Endocrinol. Metab., 2003, 88 (4), 1577-86
122. Bagnasco, M.; Kalra, P. S.; Kalra, S. P. Ghrelin and leptin pulse discharge in fed and fasted rats. Endocrinology, 2002, 143 (2), 726-9
123. Asakawa, A.; Inui, A.; Kaga, T.; Yuzuriha, H.; Nagata, T.; Ueno, N.; Makino, S.; Fujimiya, M.; Niijima, A.; Fujino, M. A.; Kasuga, M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology, 2001, 120 (2), 337-45
124. Lippl, F.; Erdmann, J.; Atmatzidis, S.; Schusdziarra, V. Direct effect of leptin on gastric ghrelin secretion. Horm. Metab. Res., 2005, 37 (2), 123-5
125. Toshinai, K.; Mondal, M. S.; Nakazato, M.; Date, Y.; Murakami, N.; Kojima, M.; Kangawa, K.; Matsukura, S. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem. Biophys. Res. Commun., 2001, 281 (5), 1220-5
126. Virgili, J.; Casals, I.; Peinado-Onsurbe, J.; Esteve, M.; Julve-Gil, J.; Fernandez-Lopez, J. A.; Remesar, X.; Alemany, M. Distribution of oleoyl-estrone in rat plasma lipoproteins. Horm. Metab. Res., 1999, 31 (11), 597-601
127. Grasa, M. M.; Esteve, M.; Masanes, R. M.; Yubero, P.; Blay, M.; Lopez-Marti, J.; Cabot, C.; Vila, R.; Fernandez-Lopez, J. A.; Remesar, X.; Alemany, M. Oral gavage of oleoyl-oestrone has a stronger effect on body weight in male Zucker obese rats than in female. Diabetes Obes. Metab., 2001, 3 (3), 203-8
128. Ferrer-Lorente, R.; Fernandez-Lopez, J.-A.; Alemany, M.; Cabot, C. Short-term oral oleoyl-estrone decreases the expression of ghrelin in the rat stomach. Regul. Pept., 2009, 152 (1-3), 79-81
129. Barkan, A. L.; Dimaraki, E. V.; Jessup, S. K.; Symons, K. V.; Ermolenko, M.; Jaffe, C. A. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J. Clin. Endocrinol. Metab., 2003, 88 (5), 2180-4
130. Campbell-Thompson, M.; Reyher, K. K.; Wilkinson, L. B. Immunolocalization of estrogen receptor alpha and beta in gastric epithelium and enteric neurons. J. Endocrinol., 2001, 171 (1), 65-73
131. Sakata, I.; Tanaka, T.; Yamazaki, M.; Tanizaki, T.; Zheng, Z.; Sakai, T. Gastric estrogen directly induces ghrelin expression and production in the rat stomach. J. Endocrinol., 2006, 190 (3), 749-57
132. Al-Massadi, O.; Crujeiras, A. B.; Gonzalez, R. C.; Pardo, M.; Dieguez, C.; Casanueva, F. F.; Seoane, L. M. Age, sex, and lactating status regulate ghrelin secretion and GOAT mRNA levels from isolated rat stomach. Am. J. Physiol. Endocrinol. Metab., 2010, 299 (3), E341-50
133. Gualillo, O.; Caminos, J. E.; Kojima, M.; Kangawa, K.; Arvat, E.; Ghigo, E.; Casanueva, F. F.; Dieguez, C. Gender and gonadal influences on ghrelin mRNA levels in rat stomach. Eur. J. Endocrinol., 2001, 144 (6), 687-90
134. Matsubara, M.; Sakata, I.; Wada, R.; Yamazaki, M.; Inoue, K.; Sakai, T. Estrogen modulates ghrelin expression in the female rat stomach. Peptides, 2004, 25 (2), 289-97
135. Kellokoski, E.; Poykko, S.M.; Karjalainen, A. H.; Ukkola, O.; Heikkinen, J.; Kesaniemi, Y. A.; Horkko, S. Estrogen replacement therapy increases plasma ghrelin levels. J. Clin. Endocrinol. Metab., 2005, 90 (5), 2954-63
136. Paulo, R. C.; Brundage, R.; Cosma, M.; Mielke, K. L.; Bowers, C. Y.; Veldhuis, J. D. Estrogen elevates the peak overnight production rate of acylated ghrelin. J. Clin. Endocrinol. Metab., 2008, 93 (11), 4440-7
137. Grinspoon, S.; Miller, K. K.; Herzog, D. B.; Grieco, K. A.; Klibanski, A. Effects of estrogen and recombinant human insulinlike growth factor-I on ghrelin secretion in severe undernutrition. J. Clin. Endocrinol. Metab., 2004, 89 (8), 3988-93
138. Wilson, C. M.; McPhaul, M. J. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol. Cell. Endocrinol., 1996, 120 (1), 51-7
139. Winborn, W. B.; Sheridan, P. J.; McGill, H. C., Jr. Sex steroid receptors in the stomach, liver, pancreas, and gastrointestinal tract of the baboon. Gastroenterology, 1987, 92 (1), 23-32
140. Pagotto, U.; Gambineri, A.; Pelusi, C.; Genghini, S.; Cacciari, M.; Otto, B.; Castaneda, T.; Tschop, M.; Pasquali, R. Testosterone replacement therapy restores normal ghrelin in hypogonadal men. J. Clin. Endocrinol. Metab., 2003, 88 (9), 4139-43
141. Naharci, M. I.; Bolu, E.; Karadurmus, N.; Basaran, Y. The relationship between ghrelin levels and insulin resistance in men with idiopathic hypogonadotrophic hypogonadism at diagnosis and after therapy. Endokrynol. Pol., 2010, 61 (4), 351-8
142. Lebenthal, Y.; Gat-Yablonski, G.; Shtaif, B.; Padoa, A.; Phillip, M.; Lazar, L. Effect of sex hormone administration on circulating ghrelin levels in peripubertal children. J. Clin. Endocrinol. Metab., 2006, 91 (1), 328-31
143. Pagotto, U.; Gambineri, A.; Vicennati, V.; Heiman, M.L.; Tschop, M.; Pasquali, R. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. The J. Clin. Endocrinol. Metab., 2002, 87 (12), 5625-9
144. Schofl, C.; Horn, R.; Schill, T.; Schlosser, H. W.; Muller, M. J.; Brabant, G. Circulating ghrelin levels in patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 2002, 87 (10), 4607-10
145. Moran, L. J.; Noakes, M.; Clifton, P. M.; Wittert, G. A.; Tomlinson, L.; Galletly, C.; Luscombe, N. D.; Norman, R. J. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J. Clin. Endocrinol. Metab., 2004, 89 (7), 3337-44
146. Wasko, R.; Komarowska, H.; Warenik-Szymankiewicz, A.; Sowinski, J. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome. Horm. Metab. Res., 2004, 36 (3), 170-3
147. Daghestani, M.H.; El-Mazny, A. Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features. Eur. J. Obstet. Gynecol. Reprod. Biol., 2011, 155 (1), 65-8
148. Reisine, T. Somatostatin. Cell. Mol. Neurobiol., 1995, 15 (6), 597-614
149. Reichlin, S. Somatostatin. N. Engl. J. Med., 1983, 309 (24), 1495-501
150. Broglio, F.; Gottero, C.; Prodam, F.; Destefanis, S.; Gauna, C.; Me, E.; Riganti, F.; Vivenza, D.; Rapa, A.; Martina, V.; Arvat, E.; Bona, G.; van der Lely, A. J.; Ghigo, E. Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans. Clin. Endocrinol., 2004, 61 (4), 503-9
151. Norrelund, H.; Hansen, T. K.; Orskov, H.; Hosoda, H.; Kojima, M.; Kangawa, K.; Weeke, J.; Moller, N.; Christiansen, J. S.; Jorgensen, J. O. L. Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin. Endocrinol., 2002, 57 (4), 539-46
152. Freda, P. U.; Reyes, C. M.; Conwell, I. M.; Sundeen, R. E.; Wardlaw, S. L. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. J. Clin. Endocrinol. Metab., 2003, 88 (5), 2037-44
153. Haqq, A. M.; Stadler, D. D.; Rosenfeld, R. G.; Pratt, K. L.; Weigle, D.S.; Frayo, R. S.; LaFranchi, S. H.; Cummings, D. E.; Purnell, J. Q. Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome. J. Clin. Endocrinol. Metab., 2003, 88 (8), 3573-6
154. Shimada, M.; Date, Y.; Mondal, M. S.; Toshinai, K.; Shimbara, T.; Fukunaga, K.; Murakami, N.; Miyazato, M.; Kangawa, K.; Yoshimatsu, H.; Matsuo, H.; Nakazato, M. Somatostatin suppresses ghrelin secretion from the rat stomach. Biochem. Biophys. Res. Commun., 2003, 302 (3), 520-5
155. Seoane, L. M.; Al-Massadi, O.; Barreiro, F.; Dieguez, C.; Casanueva, F. F. Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system. J. Endocrinol. Invest., 2007, 30 (9), RC22-5
156. Luque, R. M.; Gahete, M. D.; Hochgeschwender, U.; Kineman, R. D. Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways. Am. J. Physiol. Endocrinol. Metab., 2006, 291 (2), E395-403
157. Fukuhara, S.; Suzuki, H.; Masaoka, T.; Arakawa, M.; Hosoda, H.; Minegishi, Y.; Kangawa, K.; Ishii, H.; Kitajima, M.; Hibi, T. Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. Am. J. Physiol. Gastrointest. Liver Physiol., 2005, 289 (1), G138-45
158. Strickertsson, J. A. B.; Dossing, K. B. V.; Aabakke, A. J.M.; Nilsson, H.-O.; Hansen, T. V. O.; Knigge, U.; Kjar, A.; Wadstrom, T.; Friis-Hansen, L. Interferon-gamma inhibits ghrelin expression and secretion via a somatostatin-mediated mechanism. World J. Gastroenterol., 2011, 17 (26), 3117-25
159. Stengel, A.; Goebel-Stengel, M.; Wang, L.; Luckey, A.; Hu, E.; Rivier, J.; Tache, Y. Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats. Neurogastroenterol. Motil., 2011, 23 (7), e294-308
160. Peino, R.; Baldelli, R.; Rodriguez-Garcia, J.; Rodriguez-Segade, S.; Kojima, M.; Kangawa, K.; Arvat, E.; Ghigo, E.; Dieguez, C.; Casanueva, F. F. Ghrelin-induced growth hormone secretion in humans. Eur. J. Endocrinol., 2000, 143 (6), R11-4
161. Seoane, L. M.; Tovar, S.; Baldelli, R.; Arvat, E.; Ghigo, E.; Casanueva, F. F.; Dieguez, C. Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur. J. Endocrinol., 2000, 143 (5), R7-9
162. Qi, X.; Reed, J.; Englander, E. W.; Chandrashekar, V.; Bartke, A.; Greeley, G. H., Jr. Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. Exp. Biol. Med., 2003, 228 (9), 1028-32
163. Nagano, M.; Chastre, E.; Choquet, A.; Bara, J.; Gespach, C.; Kelly, P.A. Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract. Am. J. Pphysiol., 1995, 268 (3 Pt 1), G431-42
164. Hammer, R. E.; Brinster, R. L.; Rosenfeld, M. G.; Evans, R. M.; Mayo, K. E. Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature, 1985, 315 (6018), 413-6
165. Sonntag, W. E.; Steger, R. W.; Forman, L. J.; Meites, J. Decreased pulsatile release of growth hormone in old male rats. Endocrinology, 1980, 107 (6), 1875-9
166. Florini, J. R.; Harned, J. A.; Richman, R. A.; Weiss, J. P. Effect of rat age on serum levels of growth hormone and somatomedins. Mech. Ageing Dev., 1981, 15 (2), 165-76
167. Englander, E. W.; Gomez, G. A.; Greeley, G. H., Jr. Alterations in stomach ghrelin production and in ghrelin-induced growth hormone secretion in the aged rat. Mech. Ageing Dev., 2004, 125 (12), 871-5
168. Akimoto, Y.; Kanai, S.; Ohta, M.; Akimoto, S.; Uematsu, H.; Miyasaka, K. Age-associated reduction of stimulatory effect of ghrelin on food intake in mice. Arch. Gerontol. Geriatr., 2012, 55(2):238-43
169. Janssen, J. A.; van der Toorn, F. M.; Hofland, L. J.; van Koetsveld, P.; Broglio, F.; Ghigo, E.; Lamberts, S. W.; Jan van der Lely, A. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur. J. Endocrinol., 2001, 145 (6), 711-6
170. Nass, R.; Liu, J.; Hellmann, P.; Coschigano, K. T.; Gaylinn, B.; Berryman, D. E.; Kopchick, J. J.; Thorner, M. O. Chronic changes in peripheral growth hormone levels do not affect ghrelin stomach mRNA expression and serum ghrelin levels in three transgenic mouse models. J. Neuroendocrinol., 2004, 16 (8), 669-75
171. Bellone, S.; Corneli, G.; Bellone, J.; Baffoni, C.; Rovere, S.; de Sanctis, C.; Bona, G.; Ghigo, E.; Aimaretti, G. Short children with familial short stature show enhancement of somatotroph secretion but normal IGF-I levels. J. Endocrinol. Invest., 2002, 25 (5), 426-30
172. Kitamura, S.; Yokota, I.; Hosoda, H.; Kotani, Y.; Matsuda, J.; Naito, E.; Ito, M.; Kangawa, K.; Kuroda, Y. Ghrelin concentration in cord and neonatal blood: relation to fetal growth and energy balance. J. Clin. Endocrinol. Metab., 2003, 88 (11), 5473-7
173. Whatmore, A. J.; Hall, C. M.; Jones, J.; Westwood, M.; Clayton, P. E. Ghrelin concentrations in healthy children and adolescents. Clin. Endocrinol., 2003, 59 (5), 649-54
174. Rigamonti, A. E.; Pincelli, A. I.; Corra, B.; Viarengo, R.; Bonomo, S.M.; Galimberti, D.; Scacchi, M.; Scarpini, E.; Cavagnini, F.; Muller, E. E. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J. Endocrinol., 2002, 175 (1), R1-5
175. Malik, I. A.; English, P. J.; Ghatei, M. A.; Bloom, S. R.; MacFarlane, I. A.; Wilding, J. P. H. The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clin. Endocrinol., 2004, 60 (1), 137-41
176. Kamegai, J.; Tamura, H.; Shimizu, T.; Ishii, S.; Sugihara, H.; Oikawa, S. Insulin-like growth factor-I down-regulates ghrelin receptor (growth hormone secretagogue receptor) expression in the rat pituitary. Regul. Pept., 2005, 127 (1-3), 203-6
177. Sakata, I.; Tanaka, T.; Matsubara, M.; Yamazaki, M.; Tani, S.; Hayashi, Y.; Kangawa, K.; Sakai, T. Postnatal changes in ghrelin mRNA expression and in ghrelin-producing cells in the rat stomach. J. Endocrinol., 2002, 174 (3), 463-71
178. Tanaka, M.; Hayashida, Y.; Nakao, N.; Nakai, N.; Nakashima, K. Testis-specific and developmentally induced expression of a ghrelin gene-derived transcript that encodes a novel polypeptide in the mouse. Biochim. Biophys. Acta, 2001, 1522 (1), 62-5
179. Kamegai, J.; Tamura, H.; Shimizu, T.; Ishii, S.; Sugihara, H.; Oikawa, S. Regulation of the ghrelin gene: growth hormonereleasing hormone upregulates ghrelin mRNA in the pituitary. Endocrinology, 2001, 142 (9), 4154-7
180. Salfen, B. E.; Carroll, J. A.; Keisler, D. H.; Strauch, T. A. Effects of exogenous ghrelin on feed intake, weight gain, behavior, and endocrine responses in weanling pigs. J. Anim. Sci., 2004, 82 (7), 1957-66
181. Mackelvie, K. J.; Meneilly, G. S.; Elahi, D.; Wong, A. C. K.; Barr, S. I.; Chanoine, J.-P. Regulation of appetite in lean and obese adolescents after exercise: role of acylated and desacyl ghrelin. J. Clin. Endocrinol. Metab., 2007, 92 (2), 648-54
182. Shiiya, T.; Ueno, H.; Toshinai, K.; Kawagoe, T.; Naito, S.; Tobina, T.; Nishida, Y.; Shindo, M.; Kangawa, K.; Tanaka, H.; Nakazato, M. Significant lowering of plasma ghrelin but not des-acyl ghrelin in response to acute exercise in men. Endocr. J., 2011, 58 (5), 335-42
183. King, J. A.; Wasse, L. K.; Stensel, D. J. The acute effects of swimming on appetite, food intake, and plasma acylated ghrelin. J. Obes., 2011, 2011
184. Cederberg, H.; Rajala, U.; Koivisto, V. M.; Jokelainen, J.; Surcel, H.M.; Keinanen-Kiukaanniemi, S.; Laakso, M. Unacylated ghrelin is associated with changes in body composition and body fat distribution during long-term exercise intervention. Eur. J. Endocrinol., 2011, 165 (2), 243-8
185. Ghanbari-Niaki, A.; Jafari, A.; Moradi, M.; Kraemer, R. R. Short-,moderate-, and long-term treadmill training protocols reduce plasma, fundus, but not small intestine ghrelin concentrations in male rats. J. Endocrinol. Invest., 2011, 34 (6), 439-43
186. Arancibia, S.; Rage, F.; Astier, H.; Tapia-Arancibia, L. Neuroendocrine and autonomous mechanisms underlying thermoregulation in cold environment. Neuroendocrinology, 1996, 64 (4), 257-67
187. Ao, Y.; Go, V. L. W.; Toy, N.; Li, T.; Wang, Y.; Song, M. K.; Reeve, J. R., Jr.; Liu, Y.; Yang, H. Brainstem thyrotropin-releasing hormone regulates food intake through vagal-dependent cholinergic stimulation of ghrelin secretion. Endocrinology, 2006, 147 (12), 6004-10
188. Miampamba, M.; Yang, H.; Sharkey, K. A.; Tache, Y. Intracisternal TRH analog induces Fos expression in gastric myenteric neurons and glia in conscious rats. Am. J. Physiol. Gastrointest. Liver Physiol., 2001, 280 (5), G979-91
189. Morrow, N. S.; Hodgson, D. M.; Garrick, T. Microinjection of thyrotropin-releasing hormone analogue into the central nucleus of the amygdala stimulates gastric contractility in rats. Brain Res., 1996, 735 (1), 141-8
190. Stengel, A.; Goebel, M.; Luckey, A.; Yuan, P.-Q.; Wang, L.; Tache, Y. Cold ambient temperature reverses abdominal surgeryinduced delayed gastric emptying and decreased plasma ghrelin levels in rats. Peptides, 2010, 31 (12), 2229-35
191. Tomasik, P. J.; Sztefko, K.; Pizon, M. The effect of short-term cold and hot exposure on total plasma ghrelin concentrations in humans. Horm. Metab. Res., 2005, 37 (3), 189-90
192. Hosoda, H.; Doi, K.; Nagaya, N.; Okumura, H.; Nakagawa, E.; Enomoto, M.; Ono, F.; Kangawa, K. Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin. Chem., 2004, 50 (6), 1077-80
193. De Vriese, C.; Gregoire, F.; Lema-Kisoka, R.; Waelbroeck, M.; Robberecht, P.; Delporte, C. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology, 2004, 145 (11), 4997-5005
194. Satou, M.; Nishi, Y.; Yoh, J.; Hattori, Y.; Sugimoto, H. Identification and characterization of acyl-protein thioesterase 1/lysophospholipase I as a ghrelin deacylation/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium. Endocrinology, 2010, 151 (10), 4765-75
195. Eubanks, L. M.; Stowe, G. N.; De Lamo Marin, S.; Mayorov, A. V.; Hixon, M. S.; Janda, K. D. Identification of alpha(2) Macroglobulin as a Major Serum Ghrelin Esterase. Angew. Chem. Int. Ed. Engl., 2011, 50 (45), 10699-702
196. Borth, W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. F.A.S.E.B. J., 1992, 6 (15), 3345-53
197. Dennis, P. B.; Jaeschke, A.; Saitoh, M.; Fowler, B.; Kozma, S.C.; Thomas, G. Mammalian TOR: a homeostatic ATP sensor. Science, 2001, 294 (5544), 1102-5
198. Cota, D.; Proulx, K.; Smith, K. A. B.; Kozma, S.C.; Thomas, G.; Woods, S.C.; Seeley, R. J. Hypothalamic mTOR signaling regulates food intake. Science, 2006, 312 (5775), 927-30
199. Varela, L.; Martinez-Sanchez, N.; Gallego, R.; Vazquez, M. J.; Roa, J.; Gandara, M.; Schoenmakers, E.; Nogueiras, R.; Chatterjee, K.; Tena-Sempere, M.; Dieguez, C.; Lopez, M.H.ypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism. J. Pathol., 2012, 227 (2), 209-22
200. Mannaa, M.; Kramer, S.; Boschmann, M.; Gollasch, M. mTOR and regulation of energy homeostasis in humans. J. Mol. Med., 2013, 91(10):1167-75
201. Inoki, K.; Corradetti, M. N.; Guan, K. L. Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet., 2005, 37 (1), 19-24
202. Khamzina, L.; Veilleux, A.; Bergeron, S.; Marette, A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesitylinked insulin resistance. Endocrinology, 2005, 146 (3), 1473-81
203. Um, S. H.; Frigerio, F.; Watanabe, M.; Picard, F.; Joaquin, M.; Sticker, M.; Fumagalli, S.; Allegrini, P. R.; Kozma, S.C.; Auwerx, J.; Thomas, G. Absence of S6K1 protects against age-and dietinduced obesity while enhancing insulin sensitivity. Nature, 2004, 431 (7005), 200-5
204. Xu, G.; Li, Y.; An, W.; Li, S.; Guan, Y.; Wang, N.; Tang, C.; Wang, X.; Zhu, Y.; Li, X.; Mulholland, M. W.; Zhang, W. Gastric mammalian target of rapamycin signaling regulates ghrelin production and food intake. Endocrinology, 2009, 150 (8), 3637-44
205. Nwokolo, C. U.; Freshwater, D. A.; O'Hare, P.; Randeva, H. S. Plasma ghrelin following cure of Helicobacter pylori. Gut, 2003, 52 (5), 637-40
206. Osawa, H.; Nakazato, M.; Date, Y.; Kita, H.; Ohnishi, H.; Ueno, H.; Shiiya, T.; Satoh, K.; Ishino, Y.; Sugano, K. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J. Clin. Endocrinol. Metab., 2005, 90 (1), 10-6
207. Suzuki, H.; Masaoka, T.; Hosoda, H.; Ota, T.; Minegishi, Y.; Nomura, S.; Kangawa, K.; Ishii, H. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut, 2004, 53 (2), 187-94
208. Bravo, L. E.; Mera, R.; Reina, J.C.; Pradilla, A.; Alzate, A.; Fontham, E.; Correa, P. Impact of Helicobacter pylori infection on growth of children: a prospective cohort study. J. Pediatr. Gastroenterol. Nutr., 2003, 37 (5), 614-9
209. Abiko, Y.; Suzuki, H.; Masaoka, T.; Nomura, S.; Kurabayashi, K.; Hosoda, H.; Kangawa, K.; Hibi, T. Enhanced plasma ghrelin levels in Helicobacter pylori-colonized, interleukin-1-receptor type 1-homozygous knockout (IL-1R1-/-) mice. World J. Gastroenterol., 2005, 11 (27), 4148-53
210. Isomoto, H.; Nakazato, M.; Ueno, H.; Date, Y.; Nishi, Y.; Mukae, H.; Mizuta, Y.; Ohtsuru, A.; Yamashita, S.; Kohno, S. Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. Am. J. Med., 2004, 117 (6), 429-32
211. Langhans, W. Bacterial products and the control of ingestive behavior: clinical implications. Nutrition, 1996, 12 (5), 303-15
212. Wang, L.; Basa, N. R.; Shaikh, A.; Luckey, A.; Heber, D.; St-Pierre, D. H.; Tache, Y. LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 291 (4), G611-20
213. Stengel, A.; Goebel, M.; Wang, L.; Reeve, J. R., Jr.; Tache, Y.; Lambrecht, N. W. G. Lipopolysaccharide differentially decreases plasma acyl and desacyl ghrelin levels in rats: potential role of the circulating ghrelin-acylating enzyme GOAT. Peptides, 2010, 31 (9), 1689-96
214. Vila, G.; Maier, C.; Riedl, M.; Nowotny, P.; Ludvik, B.; Luger, A.; Clodi, M. Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J. Clin. Endocrinol. Metab., 2007, 92 (10), 3930-4
215. Madison, L. D.; Scarlett, J.M.; Levasseur, P.; Zhu, X.; Newcomb, K.; Batra, A.; Bowe, D.; Marks, D. L. Prostacyclin signaling regulates circulating ghrelin during acute inflammation. J. Endocrinol., 2008, 196 (2), 263-73
216. Burgess, W.; Gheusi, G.; Yao, J.; Johnson, R. W.; Dantzer, R.; Kelley, K. W. Interleukin-1beta-converting enzyme-deficient mice resist central but not systemic endotoxin-induced anorexia. Am. J. Physiol., 1998, 274, R1829-33
217. Al Massadi, O.; Tschop, M.H.; Tong, J. Ghrelin acylation and metabolic control. Peptides, 2011, 32 (11), 2301-8
218. Muller, T. D.; Perez-Tilve, D.; Tong, J.; Pfluger, P. T.; Tschop, M.H. Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia. J. Cachexia Sarcopenia Muscle, 2010, 1 (2), 159-167
219. Zorrilla, E. P.; Iwasaki, S.; Moss, J. A.; Chang, J.; Otsuji, J.; Inoue, K.; Meijler, M. M.; Janda, K. D. Vaccination against weight gain. Proc. Natl. Acad. Sci. U.S.A., 2006, 103 (35), 13226-31
220. Shearman, L. P.; Wang, S. P.; Helmling, S.; Stribling, D.S.; Mazur, P.; Ge, L.; Wang, L.; Klussmann, S.; Macintyre, D. E.; Howard, A.D.; Strack, A. M. Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice. Endocrinology, 2006, 147 (3), 1517-26
221. Rediger, A.; Piechowski, C. L.; Yi, C. X.; Tarnow, P.; Strotmann, R.; Gruters, A.; Krude, H.; Schoneberg, T.; Tschop, M.H.; Kleinau, G.; Biebermann, H.M.utually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. J. Biol. Chem., 2011, 286 (45), 39623-31
222. Muller, T. D.; Muller, A.; Yi, C. X.; Habegger, K. M.; Meyer, C. W.; Gaylinn, B. D.; Finan, B.; Heppner, K.; Trivedi, C.; Bielohuby, M.; Abplanalp, W.; Meyer, F.; Piechowski, C. L.; Pratzka, J.; Stemmer, K.; Holland, J.; Hembree, J.; Bhardwaj, N.; Raver, C.; Ottaway, N.; Krishna, R.; Sah, R.; Sallee, F. R.; Woods, S.C.; Perez-Tilve, D.; Bidlingmaier, M.; Thorner, M. O.; Krude, H.; Smiley, D.; DiMarchi, R.; Hofmann, S.; Pfluger, P. T.; Kleinau, G.; Biebermann, H.; Tschop, M.H. The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms. Nat. Commun., 2013, 4, 1968
223. Barnett, B. P.; Hwang, Y.; Taylor, M. S.; Kirchner, H.; Pfluger, P. T.; Bernard, V.; Lin, Y. Y.; Bowers, E. M.; Mukherjee, C.; Song, W. J.; Longo, P.A.; Leahy, D. J.; Hussain, M. A.; Tschop, M.H.; Boeke, J. D.; Cole, P.A. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science, 2010, 330 (6011), 1689-92
224. Hotta, M.; Ohwada, R.; Akamizu, T.; Shibasaki, T.; Takano, K.; Kangawa, K. Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocr. J., 2009, 56 (9), 1119-28
225. Neary, N. M.; Small, C. J.; Wren, A. M.; Lee, J. L.; Druce, M. R.; Palmieri, C.; Frost, G. S.; Ghatei, M. A.; Coombes, R. C.; Bloom, S. R. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab., 2004, 89 (6), 2832-6
226. Nagaya, N.; Moriya, J.; Yasumura, Y.; Uematsu, M.; Ono, F.; Shimizu, W.; Ueno, K.; Kitakaze, M.; Miyatake, K.; Kangawa, K. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation, 2004, 110 (24), 3674-9
227. DeBoer, M. D.; Zhu, X. X.; Levasseur, P.; Meguid, M. M.; Suzuki, S.; Inui, A.; Taylor, J. E.; Halem, H. A.; Dong, J. Z.; Datta, R.; Culler, M. D.; Marks, D. L. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology, 2007, 148 (6), 3004-12
228. Caballero, J.; Zampini, F. M.; Collina, S.; Fernandez, M. Quantitative structure-activity relationship modeling of growth hormone secretagogues agonist activity of some tetrahydroisoquinoline 1-carboxamides. Chem. Biol. Drug Des., 2007, 69 (1), 48-55
229. Sharma, S.; Sharma, B. K.; Pilania, P.; Singh, P.; Prabhakar, Y. S. Modeling of the growth hormone secretagogue receptor antagonistic activity using chemometric tools. J. Enzyme Inhib. Med. Chem., 2009, 24 (4), 1024-33
230. Sivertsen, B.; Lang, M.; Frimurer, T. M.; Holliday, N. D.; Bach, A.; Els, S.; Engelstoft, M. S.; Petersen, P. S.; Madsen, A. N.; Schwartz, T. W.; Beck-Sickinger, A. G.; Holst, B. Unique interaction pattern for a functionally biased ghrelin receptor agonist. J. Biol. Chem., 2011, 286 (23), 20845-60
231. Pedretti, A.; Vistoli, G. Modeling of human ghrelin receptor (hGHS-R1a) in its close state and validation by molecular docking. Bioorg. Med. Chem., 2007, 15 (8), 3054-64
232. Xin, Z.; Serby, M. D.; Zhao, H.; Kosogof, C.; Szczepankiewicz, B. G.; Liu, M.; Liu, B.; Hutchins, C. W.; Sarris, K. A.; Hoff, E. D.; Falls, H. D.; Lin, C. W.; Ogiela, C. A.; Collins, C. A.; Brune, M. E.; Bush, E. N.; Droz, B. A.; Fey, T. A.; Knourek-Segel, V. E.; Shapiro, R.; Jacobson, P. B.; Beno, D. W.; Turner, T. M.; Sham, H. L.; Liu, G. Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists. J. Med. Chem., 2006, 49 (15), 4459-69
233. Pantel, J.; Legendre, M.; Cabrol, S.; Hilal, L.; Hajaji, Y.; Morisset, S.; Nivot, S.; Vie-Luton, M. P.; Grouselle, D.; de Kerdanet, M.; Kadiri, A.; Epelbaum, J.; Le Bouc, Y.; Amselem, S. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J. Clin. Invest., 2006, 116 (3), 760-8
234. Caballero, J.; Fernandez, L.; Garriga, M.; Abreu, J. I.; Collina, S.; Fernandez, M. Proteometric study of ghrelin receptor function variations upon mutations using amino acid sequence autocorrelation vectors and genetic algorithm-based least square support vector machines. J. Mol. Graph. Model., 2007, 26 (1), 166-78
235. Holst, B.; Nygaard, R.; Valentin-Hansen, L.; Bach, A.; Engelstoft, M. S.; Petersen, P. S.; Frimurer, T. M.; Schwartz, T. W. A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors. J. Biol. Chem., 2010, 285 (6), 3973-85
236. Holst, B.; Holliday, N. D.; Bach, A.; Elling, C. E.; Cox, H.M.; Schwartz, T. W. Common structural basis for constitutive activity of the ghrelin receptor family. J. Biol. Chem., 2004, 279 (51), 53806-17.